• Latest Posts

Biotech of the week: PsiOxus, “non-traditional” Immuno-oncology from Oxford

A €1.3M Start-Up is Engineering Baker’s Yeast to Make Green House Gases Useful

Ablynx Top Trumps: Adding Danish Diabetes Giant Novo Nordisk to its Biotech Deck

The UK-Israeli €378M Small-Molecule Offensive Against Migraines

Novartis Attacks Amgen. Amgen wants to Ruin Roche – The New Biosimilar War!

Why Biotech Companies Should Care About Native Advertising?

ADVERTISEMENT

Money Money Money for Immuno-Oncology: BMS Joins up with a Top German VC

2015 Review: What Exciting Developments Have Been Made in Neurodegenerative Disease?

Next Generation Sequencing: the final step to massively adopt Personalized Medicine

Finally, Pfizer acquires Botox-maker Allergan for €150Bn to move to tax-friendly Ireland!

Making Propane From Gut-Bacteria: A UK-Finland Team Want to Say Ciao to Fracking

What happened this week? Genfit, History of Biotech, Cellectis

ADVERTISEMENT